Method of measuring efficacy of treatment for an autoimmune disease in vivarium animals
AssigneeRecursion Pharmaceuticals, Inc.
InventorsLaura Schaevitz, Daniel J. Ford
Life of this patent
Estimating the term…
Loading patent…
AssigneeRecursion Pharmaceuticals, Inc.
InventorsLaura Schaevitz, Daniel J. Ford
Estimating the term…
A method of measuring efficacy of test treatment of an autoimmune disease in an animal in a vivarium is described. Animal activity data is collected at multiple times during the night. Sequential time regions of the night are identified as high-activity, activity-drop, or low-activity regions. Embodiments are described to quantify a drop, during the night, of an animal's activity level. These quantified activity-drop scalars for consecutive nights are accumulated in an animal health dataset. This dataset is compared to healthy animals, a standard of care or a reference treatment for the first disease to determine efficacy of the test treatment. One embodiment quantifies an activity-drop by fitting straight-line curves through the data in the three nightly regions. Other embodiment uses a Fourier transform on a circle, LASSO, RANSAC or regression analyses for curve fitting. Another embodiment compares areas under data curves in the regions. Animals may be housed in cages with other animals.
A method of measuring efficacy of a first treatment of an autoimmune disease in a study animal in a vivarium comprising the steps of:
Dependencies are inferred from the claim text.